Yi et al. found that EZH2 inhibitsTIMP2 expression via H3K27me3 and DNA methylation, by which mean it relieves MMP repression and facilitates migration and invasion of ovarian cancer cells [27]. Here, EZH2 is linked to ovarian carcinoma.